Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 71335-1558

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 71335-1558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351558)

This is a description of a medication called Rabeprazole. It is a yellow round tablet, with the imprint Y70, containing 20mg of Sod. DR. It is manufactured by Aurobindo Pharma USA, Inc. and is used to treat acid reflux disease. The medication should be stored at room temperature and kept out of reach from children. This particular package contains 90 tablets, with the expiration date marked as MM/YY. The NDC code for this medication is 7133515582 02733901523487.*

FDA Label Image

Rabeprazole Fig1

This is a table showing the mean scores for heartburn in a study with three groups. The first group received a placebo (n=68), the second group received 10mg of RAB (n=64), and the third group received 20mg of RAB (n=67). The heartburn scores ranged from 0 to 4, with 0 indicating no heartburn and 4 indicating very severe heartburn.*

FDA Label Image

Figure 2: Mean Daytime Heartburn Scores Rab-usa-2 (Rabeprazole Fig2)

The text provides a table with data on the mean score of heartburn for placebo and different doses of RAB. The scores range from 0 (no heartburn) to 4 (very severe heartburn) and were measured on study days 0, 7, 14, 21, and 28. The placebo group had "n" participants, and RAB10mg and RAB20mg groups had 64 and 67 participants, respectively. No further information is available.*

FDA Label Image

Figure 3: Mean Nighttime Heartburn Scores Rab-usa-2 (Rabeprazole Fig3)

This is a clinical study comparing the mean heartburn scores between a placebo group of 58 participants and a group of 59 participants who received 20mg of RAB. Heartburn scores ranged from 0 (none) to 4 (very severe).*

FDA Label Image

Figure 4: Mean Daytime Heartburn Scores Rab-usa-3 (Rabeprazole Fig4)

This appears to be a table or chart displaying data on heartburn scores for a study involving a placebo and a medication called RAB20mg. The scores range from 0 (none) to 4 (very severe) and are likely used to evaluate the effectiveness of the medication in treating heartburn.*

FDA Label Image

Chemical Structure (Rabeprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.